Objective: This study aims to establish an effective predictive model for predicting Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma (TFE3-RCC) and develop optimal therapeutic strategies.
Methods: Data from 4961 patients diagnosed with renal cell carcinoma at two medical centers in China were retrospectively analyzed.